0.03
0.00%
Close of 5 Nov 2026, in USD
About Tanke Biosciences
From its filings with the US Securities and Exchange Commission
Tanke Biosciences is based in Pearl River New City Guangzhou, China and is incorporated in Nevada. Its shares trade on OTC under the ticker TNBI. The SEC classifies its business as grain mill products. In the fiscal year to 31 December 2012, it reported revenue of $28.6m and a net loss of $210,247. At that date it held total assets of $28.8m and shareholders' equity of $15.8m.
We conduct our business through our subsidiaries, principally our wholly-owned subsidiary China Flying Development Limited (“China Flying”), a Hong Kong incorporated company, and its wholly-owned subsidiary Guangzhou Kanghui Agricultural Technology Co., Ltd. (“Kanghui Agricultural” or the “WFOE”), a wholly foreign owned enterprise incorporated as a limited liability company under the laws of the PRC. We operate and control Guangzhou Tanke through Kanghui Agricultural and China Flying and in connection with the VIE Agreements.
Through Guangzhou Tanke, our principal operating business, we are one of the leading animal nutrition and innovative feed additive providers in China. Our products are distinguished from traditional artificial feed additives in that they are environmental-friendly and are designed to optimize the growth and health of livestock such as pigs, poultry and cattle, as well as farmed fish. One of our most popular products is an organic trace mineral additive that we believe is one of the few Chinese-developed organic products in the trace mineral market.
In 2001, we were designated a certified hi-tech company by the Guangzhou City Commission of Science and Technology as recognition for new technology that we developed in the agricultural industry, and in addition to our headquarters, we operate in a modern 34,000 square-meter manufacturing facility in the Huadu Economic District, Guangzhou City, Guangdong province. As the Chinese economy continues to evolve and prosper, the opportunity for technology companies like the Company should increase dramatically.
Quoted from its 10-K, filed 15 Apr 2013. Read the filing on SEC.gov ↗
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 10 Feb 2011
- Employees
- 130
- Website
- tanke-bio.com ↗
- Head office
- ROOM 2801, EAST TOWER OF HUI HAO BLDG, PEARL RIVER NEW CITY GUANGZHOU, F4, 510627
- Incorporated in
- NV
- Classification
- Grain Mill Products
Leadership
Pay as last reported
- Mr. John HopkinsExecutive Chairman of the Board, since 2025
- Mr. Vincent RenzChief Executive Officer, Director, since 2025
- Mr. Tom SteinChief Operating Officer
- Dr. Xugang ShuVice President - Research & Development$71,280
- Bo JunMarketing Director$63,360
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Strong Research and Development Capabilities: Tanke Biosciences Corp has a highly skilled team of scientists and researchers dedicated to advancing bio-based technologies.
- Innovative Product Portfolio: The company's product range includes cutting-edge biotechnology solutions that address various industries such as healthcare, agriculture, and environmental conservation.
- Strategic Partnerships: Tanke Biosciences Corp has established partnerships with leading academic institutions and industry experts, enabling collaborative research and knowledge exchange.
Weaknesses
- Limited Market Penetration: The company faces challenges in reaching a wider customer base due to intense competition and market saturation in the biotechnology industry.
- Reliance on Intellectual Property: Tanke Biosciences Corp's success heavily relies on the protection and enforcement of its intellectual property rights, which could be subject to legal disputes or infringement.
- High Research Costs: Developing bio-based technologies requires significant financial investment, which puts strain on the company's resources and profitability.
Opportunities
- Growing Demand for Sustainable Solutions: The increasing focus on sustainability and environmental conservation presents an opportunity for Tanke Biosciences Corp to capitalize on its bio-based products.
- Expansion into Emerging Markets: Exploring untapped markets, especially in developing countries, can help the company access new customer segments and drive growth.
- Technological Advancements: Leveraging advancements in biotechnology and related fields can enable Tanke Biosciences Corp to develop more advanced and competitive products.
Threats
- Regulatory and Compliance Challenges: The biotechnology industry is subject to strict regulations and compliance requirements, which may impact the company's operations and product development timelines.
- Competitive Landscape: Tanke Biosciences Corp faces intense competition from well-established biotechnology companies, requiring continuous innovation and differentiation.
- Economic Uncertainty: Economic downturns or fluctuations can impact the funding available for research and development, potentially hindering the company's growth prospects.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.